Moreover, the genomic analysis of human gliomas revealed frequent focal deletions of ERRFI1, suggesting that the loss of MIG6 activity may contribute to the development of GBM through aberrant activation of EGFR [19, 21]. This evidence concerns the gene ERRFI1 and central nervous system cancer.